Ill-defined neurological syndromes with autoimmune background: A diagnostic challenge

Journal of Rheumatology

Volumn 34, Issue 2, 2007, Pages 341-345

  Mavragani, Clio P ^a,d   Patronas, Nicholas ^b   Dalakas, Marinos ^b,c   Moutsopoulos, Haralampos M ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

Autoimmune thyroid disease; Ill defined neurological syndromes; MTHFR reductase mutations; Multiple sclerosis like disease

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); THYROID ANTIBODY;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONNECTIVE TISSUE DISEASE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EVOKED RESPONSE; FEMALE; GENE MUTATION; HOMOZYGOSITY; HUMAN; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SALIVARY GLAND BIOPSY; VASCULITIS;

ADULT; AUTOANTIBODIES; AUTOIMMUNE DISEASES; AUTOIMMUNITY; BRAIN; CENTRAL NERVOUS SYSTEM DISEASES; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HOMOZYGOTE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MULTIPLE SCLEROSIS; MUTATION; SPINAL CORD; SYNDROME; TELENCEPHALON; THYROID GLAND;

EID: 33846963134     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Trojano M, Paolicelli D. The differential diagnosis of multiple sclerosis: classification and clinical features of relapsing and progressive neurological syndromes. Neurol Sci 2001;22 Suppl 2:S98-102.
2. Cuadrado MJ, Khamashta MA, Ballesteros A, Godfrey T, Simon MJ, Hughes GRV. Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature. Medicine (Baltimore) 2000;79:57-68.
3. Arnold DL, Matthews PM. MRI in the diagnosis and management of multiple sclerosis. Neurology 2002;58 Suppl 4:S23-31.
4. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001;50:121-7.
5. Klippel JH, Stone JH, Crofford I. Primer on the rheumatic diseases. 12th ed. Atlanta: The Arthritis Foundation; 2001.
6. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309-11.
7. Vitali C, Bombardieri S, Jonsson R, et al. European Study Group on Classification Criteria for Sjogren's Syndrome. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
8. Zalavras CG, Giotopoulou S, Dokou E, et al. Lack of association between the C677T mutation in the 5,10-methylenetetrahydrofolate reductase gene and venous thromboembolism in Northwestern Greece. Int Angiol 2002;21:268-71.
9. Kohara K, Fujisawa M, Ando F, et al. MTHFR gene polymorphism as a risk factor for silent brain infarcts and white matter lesions in the Japanese general population: The NILS-LSA Study. Stroke 2003;34:1130-5. Epub 2003 Apr 10.
10. Adjalla CE, Amouzou EK, Sanni A, et al. Low frequency of mutated methylenetetrahydrofolate reductase 677C-T and 1298A-C genetics single nucleotide polymorphisms in Sub-Saharan populations. Clin Chem Lab Med 2003;41:1028-32.
11. Vrethem M, Mattsson E, Hebelka H, et al. Increased plasma homocysteine levels without signs of vitamin B12 deficiency in patients with multiple sclerosis assessed by blood and cerebrospinal fluid homocysteine and methylmalonic acid. Mult Scler 2003;9:239-45.
12. Afeltra A, Vadacca M, Conti L, et al. Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors. Arthritis Rheum 2005;53:452-9.
13. Petri M, Roubenoff R, Dallal GE, Nadeau MR, Selhub J, Rosenberg IH. Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. Lancet 1996;348:1120-4.
14. Awad IA, Spetzler RF, Hodak JA, Awad CA, Carey R. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with age and cerebrovascular risk factors. Stroke 1986;17:1084-9.
15. Chong JY, Rowland LP, Utiger RD. Hashimoto encephalopathy: syndrome or myth? Arch Neurol 2003;60:164-71.